Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$110K Sell
852
-30
-3% -$3.51K 0.06% 145
2026
Q1
$107K Sell
882
-550
-38% -$63.5K 0.05% 151
2025
Q4
$152K Hold
1,432
– – 0.08% 132
2025
Q3
$120K Sell
1,432
-550
-28% -$45.3K 0.07% 138
2025
Q2
$157K Buy
1,982
+820
+71% +$65.2K 0.1% 140
2025
Q1
$104K Hold
1,162
– – 0.07% 149
2024
Q4
$116K Buy
1,162
+100
+9% +$10.3K 0.07% 147
2024
Q3
$121K Buy
+1,062
New +$126K 0.08% 151

Other funds holding MRK

Hara Capital's MRK Position: Q2 2026 in Review

Hara Capital reduced its Merck (MRK) stake by 3.4% in Q2 2026, selling an estimated $3.51K and leaving 852 shares worth $110K. The position accounts for 0.06% of the portfolio, ranked #145.

Hara Capital first reported a position in MRK in Q3 2024 and has held it in 8 quarters since. The position peaked at $157K in Q2 2025. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Hara Capital held 852 shares of Merck worth $110K as of Q2 2026.
  • Hara Capital sold 30 Merck shares in Q2 2026, an estimated $3.51K.
  • Merck made up 0.06% of Hara Capital's portfolio in Q2 2026, its #145 holding.
  • Hara Capital first reported a position in Merck in Q3 2024 and has held it in 8 quarters since.
  • Hara Capital's Merck position peaked at $157K in Q2 2025.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.